Epstein-Barr Virus Infection and Thiopurine Therapy in a Pediatric Population with Inflammatory Bowel Disease
-
Published:2020
Issue:5
Volume:27
Page:318-323
-
ISSN:2341-4545
-
Container-title:GE - Portuguese Journal of Gastroenterology
-
language:en
-
Short-container-title:GE Port J Gastroenterol
Author:
Espinheira Maria Do Céu,
Pais Isabel Pinto,
Afonso Ivete,
Ferreira Jorge,
Trindade Eunice,
Amil-Dias JorgeORCID
Reference26 articles.
1. Epstein MA. Reflections on Epstein-Barr virus: some recently resolved old uncertainties. J Infect. 2001 Aug;43(2):111–5.
2. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010 May;362(21):1993–2000.
3. Crawford DH, Macsween KF, Higgins CD, Thomas R, McAulay K, Williams H, et al. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis. 2006 Aug;43(3):276–82.
4. Hradsky O, Copova I, Zarubova K, Durilova M, Nevoral J, Maminak M, et al. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease. Dig Dis Sci. 2015 Nov;60(11):3399–407.
5. Linton MS, Kroeker K, Fedorak D, Dieleman L, Fedorak RN. Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study. Aliment Pharmacol Ther. 2013 Nov;38(10):1248–54.